ANGIONEUROTIC-EDEMA AND URTICARIA DURING THERAPY WITH INTERLEUKIN-2 (IL-2)

被引:8
作者
BAARS, JW [1 ]
WAGSTAFF, J [1 ]
HACK, CE [1 ]
WOLBINK, GJ [1 ]
EERENBERGBELMER, AJM [1 ]
PINEDO, HM [1 ]
机构
[1] NETHERLANDS RED CROSS,DEPT AUTOIMMUNE DIS,BLOOD TRANSFUS SERV,CENT LAB,AMSTERDAM,NETHERLANDS
关键词
D O I
10.1093/oxfordjournals.annonc.a058162
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:243 / 244
页数:2
相关论文
共 8 条
[1]  
BAARS JW, IN PRESS BR J CANCER
[2]   A NEW REGIMEN OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS - EFFICACY WITHOUT SIGNIFICANT TOXICITY [J].
EBERLEIN, TJ ;
SCHOOF, DD ;
JUNG, SE ;
DAVIDSON, D ;
GRAMOLINI, B ;
MCGRATH, K ;
MASSARO, A ;
WILSON, RE .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (12) :2571-2576
[3]  
HACK GE, 1991, THROMB HAEMOSTASIS, V65, P497
[4]  
METZGER WJ, 1985, ALLERGIC DISEASES, P440
[5]  
NUIJENS JH, 1987, THROMB HAEMOSTASIS, V58, P778
[6]   ACQUIRED DEFICIENCY OF THE INHIBITOR OF THE 1ST COMPONENT OF COMPLEMENT - REPORT OF 5 ADDITIONAL CASES WITH COMMENTARY ON THE SYNDROME [J].
SHEFFER, AL ;
AUSTEN, KF ;
ROSEN, FS ;
FEARON, DT .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1985, 75 (06) :640-646
[7]   INTERLEUKIN-2 TOXICITY [J].
SIEGEL, JP ;
PURI, RK .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (04) :694-704
[8]  
THIJS LG, 1990, J IMMUNOL, V144, P2419